The company's products are nutritional supplements that utilize the Akkermansia bacteria, which has been found to improve metabolic and inflammatory disorders. A-Mansia conducts its research and development in collaboration with the University of Louvain and Wageningen University, and aims to provide physicians with effective treatments for obesity-related diseases. The Akkermansia bacteria, located in the mucus layer of the intestinal epithelium, allows for close communication with the host, making it a promising target for developing health products.